The Mission (The "What")

Vid Biosciences Inc. is a translational science company operating in stealth mode to develop a proprietary, modality-agnostic platform for the identification of novel therapeutic candidates. We are dedicated to bridging the gap between deep biological insights and clinical applications for rare and neglected genetic disorders with high unmet medical needs.

The Technology (The "How")

Our discovery engine leverages high-throughput screening and advanced modeling to optimize the identification of high-value leads within complex biological pathways. By focusing on precision-driven discovery, Vid Biosciences aims to unlock new therapeutic windows for diseases that have remained historically difficult to address with traditional approaches.

Leadership & Status (The "Who")

Founded in 2026 and based in the Cambridge/Boston biotech ecosystem, Vid Biosciences is led by a PhD scientist with over 10 years of experience in translational science, in vivo pharmacology, and therapeutic development. The company is a Delaware-incorporated entity currently focused on platform validation and early-stage lead optimization.